Related Experiment Video

Updated: Dec 1, 2025

Quantification of Protein Interaction Network Dynamics using Multiplexed Co-Immunoprecipitation
07:57

Quantification of Protein Interaction Network Dynamics using Multiplexed Co-Immunoprecipitation

Published on: August 21, 2019

8.9K

NCI-MATCH Sets "Benchmark of Actionability"

    Cancer Discovery
    |November 10, 2020
    PubMed

    Insights

    The Molecular Analysis for Therapy Choice trial showed it is possible to match cancer patients to targeted therapies using tumor DNA sequencing. However, the effectiveness of these targeted treatments was limited, with generally low response rates observed.

    Area of Science:

    • Oncology
    • Genomics
    • Precision Medicine

    Background:

    • The NCI Molecular Analysis for Therapy Choice (MATCH) trial investigated the feasibility of matching patients to targeted therapies based on tumor molecular alterations.
    • This trial aimed to determine if comprehensive genomic profiling could guide treatment selection in cancer patients.

    Discussion:

    • While the trial successfully demonstrated the feasibility of molecular profiling and treatment assignment, the overall response rates to the assigned targeted therapies were low.
    • This suggests a gap between identifying targetable mutations and achieving significant clinical benefit.

    Key Insights:

    • Tumor DNA sequencing is a feasible approach for identifying actionable mutations in cancer patients.
    • Matching patients to therapies based on genomic profiles is achievable in a clinical trial setting.
    • Low response rates indicate challenges in the efficacy of current targeted therapies or the selection criteria.

    Outlook:

    • Further research is needed to improve the efficacy of targeted therapies and optimize patient selection strategies.
    • Exploring novel therapeutic combinations and biomarkers may enhance treatment outcomes in precision oncology.
    • The findings highlight the need for continued innovation in molecularly guided cancer treatment.

    More Related Videos

    Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors11:15

    Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

    Published on: September 20, 2016

    24.8K
    Author Spotlight: A Novel Setup to Conduct Naturalistic Laboratory Experiments with Real Human Actors in Scenarios07:43

    Author Spotlight: A Novel Setup to Conduct Naturalistic Laboratory Experiments with Real Human Actors in Scenarios

    Published on: August 4, 2023

    2.5K

    Related Concept Videos

    Multiple Comparison Tests01:13

    Multiple Comparison Tests

    Multiple comparison test, abbreviated as MCT, is a post hoc analysis generally performed after comparing multiple samples with one or more tests. An MCT will help identify a significantly different sample among multiple samples or a factor among multiple factors.
    It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...
    4.3K
    Wilcoxon Signed-Ranks Test for Matched Pairs01:09

    Wilcoxon Signed-Ranks Test for Matched Pairs

    The Wilcoxon signed-rank test for matched pairs evaluates the null hypothesis by combining the ranks of differences with their signs. It essentially tests whether the median of the differences in a population of matched pairs is zero. Since the test incorporates more information than the sign test, it generally yields more trustable conclusions. This test also does not require the data to follow a normal distribution, but two conditions must be met for it to be applicable: (1) the data must...
    327